Advertisement
Australia markets closed
  • ALL ORDS

    8,094.30
    -111.20 (-1.36%)
     
  • AUD/USD

    0.6526
    -0.0057 (-0.87%)
     
  • ASX 200

    7,861.20
    -102.50 (-1.29%)
     
  • OIL

    76.27
    -1.32 (-1.70%)
     
  • GOLD

    2,372.60
    -43.10 (-1.78%)
     
  • Bitcoin AUD

    98,474.16
    -3,433.00 (-3.37%)
     
  • CMC Crypto 200

    1,310.26
    -27.92 (-2.09%)
     

UPDATE - Inspire Medical Systems, Inc. to Present at the BofA Securities Health Care Conference 2023

Inspire Medical Systems
Inspire Medical Systems

MINNEAPOLIS, May 03, 2023 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire), a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea, announced today that its management team will present at the BofA Securities Health Care Conference 2023 on Wednesday, May 10, 2023.

Inspire is now scheduled to present at 1:00 p.m. Eastern Time. The presentation will be accessible via a live webcast here.

A webcast replay of the presentation will be available for two weeks following the presentation in the Event Archive section of Inspire’s Investor website at https://investors.inspiresleep.com.

ADVERTISEMENT

About Inspire Medical Systems
Inspire is a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea. Inspire’s proprietary Inspire therapy is the first and only FDA-approved neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea.

For additional information about Inspire, please visit www.inspiresleep.com.

Investor and Media Contact
Ezgi Yagci
Vice President, Investor Relations
ezgiyagci@inspiresleep.com
617-549-2443